Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Skyline Medical Inc. Expands International Presence by Signing Distribution Agreements in Canada and Switzerland
MINNEAPOLIS , Nov. 07, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced it has partnered with two independent distributors to support
View HTML
Toggle Summary Skyline Medical Inc. Enters into Strategic Collaboration with Helomics to Develop Next Generation of Personalized Cancer Diagnostics
MINNEAPOLIS , Nov. 01, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, and Helomics Corporation ( Pittsburgh, PA )  have announced a strategic
View HTML
Toggle Summary Skyline Medical to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
MINNEAPOLIS, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY ® System for automated, direct-to-drain medical fluid disposal, today announced that management will present at the Dawson James Securities 3rd
View HTML
Toggle Summary Skyline Medical Provides Update on Pending Merger with CytoBioscience
MINNEAPOLIS, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY ® System for automated, direct-to-drain medical fluid disposal, provides an update on progress toward completing its merger with CytoBioscience.
View HTML
Toggle Summary Skyline Medical Enters Innovative Technology Partnership with Intalere for STREAMWAY® System
Provides access to more than 90,000 members, including 3,733 hospitals
View HTML
Toggle Summary Skyline Medical Reports 2017 Second Quarter Financial Results
Conference call begins at 11:00 a.m. Eastern time tomorrow August 15
View HTML
Toggle Summary Skyline Medical Signs Definitive Merger Agreement With CytoBioscience
Conference call begins at 11:00 a.m. Eastern time on August 15 Definitive Merger Agreement signed, calling for issuance of Skyline common and preferred stock Skyline Medical expands revenue stream into growth markets with CytoBioscience for their ion channel screening and protein solubility
View HTML
Toggle Summary Skyline Medical Signs Binding Letter of Intent for Merger Transaction with CytoBioscience
MINNEAPOLIS, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY ® System for automated, direct-to-drain medical fluid disposal, announces the signing of a binding letter of intent for a merger transaction with
View HTML
Toggle Summary Skyline Medical Issues Letter to Stockholders
MINNEAPOLIS, June 29, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today issued the following letter to stockholders, which may be found on its
View HTML
Toggle Summary Skyline Medical Announces CE Mark for the STREAMWAY® System
MINNEAPOLIS, June 15, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that its European Authorized Representative, Emergo Europe B.V., has
View HTML